Article Versions Notes

Köck R, Denkel L, Feßler AT, Eicker R, Mellmann A, Schwarz S, Geffers C, Hübner N-O, Leistner R. Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review. Pathogens. 2023; 12(4):612. https://doi.org/10.3390/pathogens12040612

Köck, Robin, Luisa Denkel, Andrea T. Feßler, Rudolf Eicker, Alexander Mellmann, Stefan Schwarz, Christine Geffers, Nils-Olaf Hübner, and Rasmus Leistner. 2023. "Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review" Pathogens 12, no. 4: 612. https://doi.org/10.3390/pathogens12040612

Köck, R., Denkel, L., Feßler, A. T., Eicker, R., Mellmann, A., Schwarz, S., Geffers, C., Hübner, N.-O., & Leistner, R. (2023). Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review. Pathogens, 12(4), 612. https://doi.org/10.3390/pathogens12040612